REGENCOR

Regencor is a regenerative medicine company focused on developing cardiac regenerative therapies that target myocardial infarction and heart failure. We have discovered and patented recombinant glycosylation variants of human circulating FSTL1 that are remarkably regenerative after cardiac injury... Through our first in class therapeutics, we aim to facilitate cardiac regeneration and scar tissue reduction after cardiac injury... Regencor's team envisions a future where myocardial infarctions no longer impose incurable & life threatening tissue damage or progression to heart failure

Also known as: Regencor, Inc.

Primary location: San Carlos United States